ID

34356

Description

Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan; ODM derived from: https://clinicaltrials.gov/show/NCT01777061

Lien

https://clinicaltrials.gov/show/NCT01777061

Mots-clés

Versions (1)
  1. 16/01/2019 16/01/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

16 janvier 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Prostate Cancer NCT01777061

Anglais

Eligibility Prostate Cancer NCT01777061

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
positive for recurrent prostate cancer by psa criteria
Description

Prostate cancer recurrent Positive | Prostate-Specific Antigen criteria

Type de données

boolean

Alias
UMLS CUI [1,1]
C0278838
UMLS CUI [1,2]
C1514241
UMLS CUI [2,1]
C0138741
UMLS CUI [2,2]
C0243161
recurrence definition:
Description

Recurrence Definition

Type de données

boolean

Alias
UMLS CUI [1,1]
C0034897
UMLS CUI [1,2]
C1704788
status post-operative radical prostatectomy, recurrence is defined by a psa of greater than or equal to 0.2 ng/ml
Description

Radical prostatectomy Postoperative state | Recurrence Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0194810
UMLS CUI [1,2]
C0231287
UMLS CUI [2,1]
C0034897
UMLS CUI [2,2]
C0201544
patients who have failed external beam radiation, or status post-brachytherapy, have recurrence as defined as psa above 2.0 ng/ml the nadir psa after treatment
Description

External Beam Radiation Therapy failed | Status post Brachytherapy | Recurrence Prostate specific antigen measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C1517033
UMLS CUI [1,2]
C0231175
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0006098
UMLS CUI [3,1]
C0034897
UMLS CUI [3,2]
C0201544
subject is able to comprehend the study objectives and provide written informed consent before the initiation of any study-related procedures.
Description

Comprehension Study Protocol | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0162340
UMLS CUI [1,2]
C2348563
UMLS CUI [2]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
eastern cooperative oncology group (ecog) status of ≥ 2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
any other concurrent malignancy
Description

Cancer Other

Type de données

boolean

Alias
UMLS CUI [1]
C1707251
patients without remission of disease (no psa decrease)
Description

Disease remission Absent | Prostatic specific antigen decrease Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0544452
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0178414
UMLS CUI [2,2]
C0332197
patients without recurrence of disease (psa remains low)
Description

Recurrent disease Absent | PSA Level low

Type de données

boolean

Alias
UMLS CUI [1,1]
C0277556
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C4086720
UMLS CUI [2,2]
C0205251
Retour au début de la page

Similar models

Eligibility Prostate Cancer NCT01777061

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Prostate cancer recurrent Positive | Prostate-Specific Antigen criteria
Item
positive for recurrent prostate cancer by psa criteria
boolean
C0278838 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0138741 (UMLS CUI [2,1])
C0243161 (UMLS CUI [2,2])
Recurrence Definition
Item
recurrence definition:
boolean
C0034897 (UMLS CUI [1,1])
C1704788 (UMLS CUI [1,2])
Radical prostatectomy Postoperative state | Recurrence Prostate specific antigen measurement
Item
status post-operative radical prostatectomy, recurrence is defined by a psa of greater than or equal to 0.2 ng/ml
boolean
C0194810 (UMLS CUI [1,1])
C0231287 (UMLS CUI [1,2])
C0034897 (UMLS CUI [2,1])
C0201544 (UMLS CUI [2,2])
External Beam Radiation Therapy failed | Status post Brachytherapy | Recurrence Prostate specific antigen measurement
Item
patients who have failed external beam radiation, or status post-brachytherapy, have recurrence as defined as psa above 2.0 ng/ml the nadir psa after treatment
boolean
C1517033 (UMLS CUI [1,1])
C0231175 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C0006098 (UMLS CUI [2,2])
C0034897 (UMLS CUI [3,1])
C0201544 (UMLS CUI [3,2])
Comprehension Study Protocol | Informed Consent
Item
subject is able to comprehend the study objectives and provide written informed consent before the initiation of any study-related procedures.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
ECOG performance status
Item
eastern cooperative oncology group (ecog) status of ≥ 2
boolean
C1520224 (UMLS CUI [1])
Cancer Other
Item
any other concurrent malignancy
boolean
C1707251 (UMLS CUI [1])
Disease remission Absent | Prostatic specific antigen decrease Absent
Item
patients without remission of disease (no psa decrease)
boolean
C0544452 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0178414 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Recurrent disease Absent | PSA Level low
Item
patients without recurrence of disease (psa remains low)
boolean
C0277556 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C4086720 (UMLS CUI [2,1])
C0205251 (UMLS CUI [2,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial